Exergame aims to cut fall risk in seniors with mild cognitive impairment
NCT ID NCT07241598
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a computer-based stepping game, called Smart±step, can help older adults with mild cognitive impairment (MCI) improve their balance, thinking, and quality of life while reducing their risk of falling. About 70 participants will use the game, which combines mental challenges with physical stepping tasks. The goal is to see if this fun, interactive approach can prevent falls and boost overall function in a group that is five times more likely to fall than other older adults.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 70 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Dec 2025
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Older people with MCI will be identified based on the core criteria outlined by the diagnostic scheme of MCI by Petersen and the National Institute on Aging-Alzheimer's Association and as follows: Subjective cognitive complaints (SCCs) will be assessed using four commonly endorsed items from Slavin et al., with a total score ≥3 indicating SCCs. Objective cognitive impairment will be determined using the Thai version of the Montreal Cognitive Assessment (MoCA), with inclusion criteria defined as MoCA scores of 20-25 for individuals with ≤12 years of education and 21-25 for those with \>12 years. Functional ability will be evaluated using the Bayer Activities of Daily Living Scale (B-ADL), with scores \<3 indicating no impairment. Participants with MoCA scores \<20 (≤12 years education) or \<21 (\>12 years) will be excluded to rule out dementia. Individuals meeting all four criteria-subjective complaints, objective cognitive impairment, preserved functional abilities, and absence of dementia-will be classified as having MCI. * Aged 60 years or more. * Thai-speaking language and able to read or understand the Thai language * Able to walk 10m independently (without a walking aid) Exclusion Criteria: * Having had a stroke in the last 2 years. * Having a progressive neurodegenerative disorder e.g. Parkinson's disease, Multiple sclerosis, amyotrophic lateral sclerosis (ALS). * Individuals who are blind, deaf, or amputees, whether the condition is congenital or acquired. * A medical condition that would interfere with the safety and conduct of the training and testing protocol or interpretation of the results, such as: 1. Musculoskeletal conditions e.g. severe pain of lower extremities (pain score \> 4/10), recent TKR/THR (less than or equal to 12 months after operation) and recent fracture (12-months). 2. Cardiopulmonary conditions e.g. unstable angina, uncontrolled hypertension. 3. Metabolic conditions e.g. severe or poorly controlled diabetes. 4. Mental health conditions e.g. severe or poorly controlled depression or psychiatric condition.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Mild cognitive impairment (MCI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Faculty of Physical Therapy
Salaya, Changwat Nakhon Pathom, 73170, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A brain zapping and tai chi combo may slow memory decline
- Can a dead probiotic revive aging brains?
- Could a breath test reveal Parkinson's risk?
- A new web tool aims to ease tough tech decisions for dementia families
- A smart wearable could detect dementia early — before symptoms worsen
- Can Brain-and-Body drills slow memory decline?